Statistics
Publications
9
Citations
222
H-Index
9
Active since
2008
Affiliations
Matthew T. Aspelund is an author at AstraZeneca (United States) specializing in biotechnology, biochemistry, and protein purification.
Publications per year
2008–2022
9
9
Monoclonal antibody fragment removal mediated by mixed mode resins
Ellen O’Connor, Matthew T. Aspelund, Frank Bartnik et al. · Journal of Chromatography A · 2017 · 41 citations · Full text
Cassia Andrade, Lindsay Arnold, Dana Motabar et al. · Biotechnology Progress · 2018 · 34 citations · Full text
Matthew T. Aspelund, Glenn Rozeboom, Meng Heng et al. · Journal of Membrane Science · 2008 · 22 citations
1–5 of 9